A highly sensitive bone marrow test could double survival rates for some groups of younger adults with Acute Myeloid Leukemia (AML) by helping doctors identify if they might relapse up to three months ...
iDenfy’s revamped AML Screening software now includes new risk categories, better PEP status labeling, and other built-in AML features Delaware, United States, October 29, 2025-- iDenfy, a global ...
Combining proteasome inhibitors with autophagy inhibitors disrupts acute myeloid leukemia (AML) cells' proteostasis, enhancing treatment efficacy and inducing programmed cell death. The novel therapy ...
Money laundering is on the rise, analysts say, as criminals exploit new technologies like artificial intelligence, crypto, and social media. AI-driven money laundering, deepfake fraud, and cybercrime ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results